MENU
+Compare
CVKD
Stock ticker: NASDAQ
AS OF
Aug 11, 04:24 PM (EDT)
Price
$10.69
Change
-$0.46 (-4.13%)
Capitalization
22.82M

CVKD Cadrenal Therapeutics Inc Forecast, Technical & Fundamental Analysis

Cadrenal Therapeutics Inc is developing tecarfarin, its drug candidate, for unmet needs in anticoagulation therapy... Show more

CVKD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for CVKD with price predictions
Aug 08, 2025

CVKD's Indicator enters downward trend

The Aroon Indicator for CVKD entered a downward trend on August 08, 2025. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 106 similar instances where the Aroon Indicator formed such a pattern. In of the 106 cases the stock moved lower. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on August 06, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on CVKD as a result. In of 45 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CVKD declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where CVKD's RSI Oscillator exited the oversold zone, of 14 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 33 cases where CVKD's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for CVKD just turned positive on August 07, 2025. Looking at past instances where CVKD's MACD turned positive, the stock continued to rise in of 25 cases over the following month. The odds of a continued upward trend are .

Following a +2 3-day Advance, the price is estimated to grow further. Considering data from situations where CVKD advanced for three days, in of 128 cases, the price rose further within the following month. The odds of a continued upward trend are .

CVKD may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.733) is normal, around the industry mean (18.662). P/E Ratio (0.000) is within average values for comparable stocks, (54.033). CVKD's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.909). Dividend Yield (0.000) settles around the average of (0.049) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (286.048).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. CVKD’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CVKD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
CVKD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

CVKD is expected to report earnings to fall 37.93% to -125 cents per share on August 11

Cadrenal Therapeutics Inc CVKD Stock Earnings Reports
Q2'25
Est.
$-1.26
Q4'24
Missed
by $1.88
Q3'24
Missed
by $2.06
Q2'24
Missed
by $2.13
Q1'24
Missed
by $0.03
The last earnings report on March 13 showed earnings per share of -202 cents, missing the estimate of -15 cents. With 10.51K shares outstanding, the current market capitalization sits at 22.82M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
822 A1A North
Phone
+1 904 300-0701
Employees
4
Web
https://www.cadrenal.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RLYB0.530.02
+3.91%
Rallybio Corp
PAYX141.190.67
+0.48%
Paychex
IBOC68.78-0.08
-0.11%
International Bancshares Corp
ELVA4.62-0.12
-2.53%
Electrovaya
QNST15.19-1.01
-6.23%
QuinStreet

CVKD and Stocks

Correlation & Price change

A.I.dvisor tells us that CVKD and GDTC have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CVKD and GDTC's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CVKD
1D Price
Change %
CVKD100%
+5.39%
GDTC - CVKD
31%
Poorly correlated
+0.54%
MNPR - CVKD
29%
Poorly correlated
-9.61%
YMAB - CVKD
27%
Poorly correlated
-0.12%
WHWK - CVKD
25%
Poorly correlated
-2.78%
RNXT - CVKD
25%
Poorly correlated
-5.00%
More